Special Article
Classification of Cardiomyopathy
The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation

https://doi.org/10.1016/j.jacc.2013.08.1644Get rights and content
Under an Elsevier user license
open archive

Key Words

cardiomyopathy
diastolic dysfunction
heart failure
heart muscle disease
myocardial hypertrophy
systolic dysfunction
ventricular arrhythmias

Cited by (0)

This study was supported by Grants European Union INHERITANCE project n°241924 and Italian Ministry of Health “Diagnosis and Treatment of Hypertrophic Cardiomyopathies” (n°RF-PSM-2008-1145809) to EA, IRCCS Policlinico San Matteo, Pavia. Dr. Greenberg is a consultant for Zensun, Celladon, Mesoblast, Novartis, and Teva Pharmaceutical; and is on the Speakers’ Bureaus of Otsuka and Boehringer Ingelheim. Dr. Kramer has received research support from Novartis (research funding) and Siemens Healthcare (equipment); and is a consultant for Synarc and St. Jude Medical. Dr. J. Narula has received research grants from GE Healthcare and Phillips. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.